Ratings by WBB Securities

Date Analyst CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/22/2025 Stephen Brozak Cidara Therapeutics CDTX Maintain Strong Buy
(N/A)
123.00
(45.00)
 
 
  Details
9/9/2025 Steve Brozak Celularity CELU Upgrade Buy
(Hold)
6.00
(N/A)
2.11
(1.21)
-42.65% Details
68 more...